Soleus Capital Management, L.P. Vanda Pharmaceuticals Inc. Transaction History

Soleus Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $1.72 Million - $2.63 Million	-158,700 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $2.2 Million - $2.96 Million	-139,900 Reduced 46.85%	158,700 $2.49 Million
Q3 2021 Nov 15, 2021	BUY	$15.35 - $21.27 $4.58 Million - $6.35 Million	298,600 New	298,600 $5.12 Million
Q2 2020 Aug 14, 2020	SELL	$9.66 - $12.02 $183,540 - $228,380	-19,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.5 - $16.8 $142,500 - $319,200	19,000 New	19,000 $197,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $270M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.